Literature DB >> 1779615

N-acetylglutamate synthetase deficiency: clinical and laboratory observations.

A L Pandya1, R Koch, F A Hommes, J C Williams.   

Abstract

Two male siblings presented in the first 6 weeks of life with emesis, diarrhoea, metabolic acidosis and lethargy. A male sibling had previously died at 14 months of age from liver failure of unknown aetiology. Both of the current cases had mild hyperammonaemia with normal orotic acid, organic acid and argininosuccinic acid levels. Citrulline and arginine levels were normal or mildly decreased. One of the brothers was biopsied and had no detectable N-acetylglutamate synthetase activity and normal values for other enzymes of the urea cycle in liver. Treatment with a low-protein diet and sodium benzoate/sodium phenylacetate resulted in near normal blood ammonia levels, except during viral illness. Subsequent neurological development has been normal to mildly delayed. These patients differ from those previously described with N-acetylglutamate synthetase deficiency in that their presentation and subsequent course were relatively benign.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1779615     DOI: 10.1007/bf01799936

Source DB:  PubMed          Journal:  J Inherit Metab Dis        ISSN: 0141-8955            Impact factor:   4.982


  10 in total

1.  Role of acetylglutamate in ureotelism. I. Occurrence and biosynthesis of acetylglutamate in mouse and rat tissues.

Authors:  K Shigesada; M Tatibana
Journal:  J Biol Chem       Date:  1971-09-25       Impact factor: 5.157

2.  Enzymatic synthesis of acetylglutamate by mammalian liver preparations and its stimulation by arginine.

Authors:  K Shigesada; M Tatibana
Journal:  Biochem Biophys Res Commun       Date:  1971-09       Impact factor: 3.575

3.  N-acetylglutamate synthetase deficiency, a second patient.

Authors:  C Bachmann; M Brandis; E Weissenbarth-Riedel; R Burghard; J P Colombo
Journal:  J Inherit Metab Dis       Date:  1988       Impact factor: 4.982

4.  N-acetylglutamate synthetase (NAGS) deficiency: diagnosis, clinical observations and treatment.

Authors:  C Bachmann; J P Colombo; K Jaggi
Journal:  Adv Exp Med Biol       Date:  1982       Impact factor: 2.622

5.  Assay of ornithine carbamoyltransferase activity in human liver using carbon-labeled ornithine and thin-layer chromatography.

Authors:  J McLaren; W G Ng
Journal:  Clin Chim Acta       Date:  1977-12-01       Impact factor: 3.786

6.  Properties of fetal and adult red blood cell arginase: a possible prenatal diagnostic test for arginase deficiency.

Authors:  E B Spector; M Kiernan; B Bernard; S D Cederbaum
Journal:  Am J Hum Genet       Date:  1980-01       Impact factor: 11.025

7.  Subcellular localization and properties of N-acetylglutamate synthase in rat small intestinal mucosa.

Authors:  C Uchiyama; M Mori; M Tatibana
Journal:  J Biochem       Date:  1981-06       Impact factor: 3.387

8.  N-Acetylglutamate synthetase: enzyme assay in human liver.

Authors:  J P Colombo; S Krähenbühl; C Backmann; P Aeberhard
Journal:  J Clin Chem Clin Biochem       Date:  1982-05

9.  Argininosuccinate lyase: purification and characterization from human liver.

Authors:  W E O'Brien; R H Barr
Journal:  Biochemistry       Date:  1981-03-31       Impact factor: 3.162

10.  Increased translatable messenger ribonucleic acid for argininosuccinate synthetase in canavanine-resistant human cells.

Authors:  T S Su; A L Beaudet; W E O'Brien
Journal:  Biochemistry       Date:  1981-05-12       Impact factor: 3.162

  10 in total
  9 in total

1.  N-carbamylglutamate enhancement of ureagenesis leads to discovery of a novel deleterious mutation in a newly defined enhancer of the NAGS gene and to effective therapy.

Authors:  Sandra K Heibel; Nicholas Ah Mew; Ljubica Caldovic; Yevgeny Daikhin; Marc Yudkoff; Mendel Tuchman
Journal:  Hum Mutat       Date:  2011-09-09       Impact factor: 4.878

2.  Null mutations in the N-acetylglutamate synthase gene associated with acute neonatal disease and hyperammonemia.

Authors:  Ljubica Caldovic; Hiroki Morizono; Maria Gracia Panglao; Sabrina F Cheng; Seymour Packman; Mendel Tuchman
Journal:  Hum Genet       Date:  2003-02-20       Impact factor: 4.132

Review 3.  Recurrent encephalopathy: NAGS (N-acetylglutamate synthase) deficiency in adults.

Authors:  A Cartagena; A N Prasad; C A Rupar; M Strong; M Tuchman; N Ah Mew; C Prasad
Journal:  Can J Neurol Sci       Date:  2013-01       Impact factor: 2.104

4.  Hyperammonaemia as a cause of psychosis in an adolescent.

Authors:  Amaya Bélanger-Quintana; Mercedes Martínez-Pardo; María José García; Bendicht Wermuth; Julián Torres; Esperanza Pallarés; Magdalena Ugarte
Journal:  Eur J Pediatr       Date:  2003-08-27       Impact factor: 3.183

Review 5.  N-acetylglutamate and its changing role through evolution.

Authors:  Ljubica Caldovic; Mendel Tuchman
Journal:  Biochem J       Date:  2003-06-01       Impact factor: 3.857

6.  A new neonatal case of N-acetylglutamate synthase deficiency treated by carbamylglutamate.

Authors:  N Guffon; C Vianey-Saban; J Bourgeois; D Rabier; J P Colombo; P Guibaud
Journal:  J Inherit Metab Dis       Date:  1995       Impact factor: 4.982

Review 7.  Neuropsychological attributes of urea cycle disorders: A systematic review of the literature.

Authors:  Susan E Waisbren; Arianna K Stefanatos; Teresa M Y Kok; Burcu Ozturk-Hismi
Journal:  J Inherit Metab Dis       Date:  2019-08-01       Impact factor: 4.982

Review 8.  Presentation and management of N-acetylglutamate synthase deficiency: a review of the literature.

Authors:  Aileen Kenneson; Rani H Singh
Journal:  Orphanet J Rare Dis       Date:  2020-10-09       Impact factor: 4.123

9.  N-acetylglutamate synthase deficiency: an insight into the genetics, epidemiology, pathophysiology, and treatment.

Authors:  Nicholas Ah Mew; Ljubica Caldovic
Journal:  Appl Clin Genet       Date:  2011-08-24
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.